Pembrolizumab

Category: Cancer

Pembrolizumab Overview

Pembrolizumab (formerly lambrolizumab, brand name Keytruda) is a humanized antibody used in cancer immunotherapy. This includes to treat melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer.[3] It is given by slow injection into a vein.[3] Common side effects include fatigue, musculoskeletal pain, decreased appetite, itchy skin (pruritus), diarrhea, nausea, rash, fever (pyrexia), cough, difficulty breathing (dyspnea), constipation, ...

Read more Pembrolizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pembrolizumab

Recent Pembrolizumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Pembrolizumab or a similar ingredient: (1 result)

• KEYTRUDA Pembrolizumab2 discussions

Related Pembrolizumab Topics: